New Home Intercranial Pressure Monitoring Device Likely To Disrupt Market

Medical technology manufacturer Raumedic has launched the Raumed Home ICP, a new home-use device for intracranial pressure (ICP) monitoring. Having recently received CE marking, the device is well positioned to access the ICP monitoring devices market, which is estimated to reach $181.9 million by 2025, growing at a compound annual growth rate (CAGR) of 2.4 percent, according to Global Data.

Sourced through from: